OCLS: Summary for Oculus Innovative Sciences, Inc - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 1:14am EST - Canadian Markets open in 8 hours and 16 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Oculus Innovative Sciences, Inc. (OCLS)

On Feb 9: 1.94 USD

0.01 (0.51%)

MORE ON OCLS

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oculus Innovative Sciences, Inc (NCM:OCLS) Delayed quote data

Last Trade:	1.94 USD
Trade Time:	Feb 9
Change:	0.01 (0.51%)
Prev Close:	1.95
Open:	1.98
Bid:	1.66 x 3200
Ask:	4.00 x 700
1y Target Est:	13.00

Day's Range:	1.89 - 2.05
52wk Range:	0.72 - 5.75
Volume:	124,486
Avg Vol (3m):	200,571
Market Cap:	47.70M
P/E (ttm):	N/A
EPS (ttm):	-2.31
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add OCLS to Portfolio

Download Data

HEADLINES

•	New Star Analyst Rankings for Oculus Innovative Sciences, Inc
	StarMine (Sat, Feb 6)

•	Oculus Innovative Sciences Reports Third Quarter FY 2010 Financial Results: 30% Reduction in Operating Expenses and 36% Increase in Product Revenue
	Business Wire (Thu, Feb 4)

•	OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
	EDGAR Online (Thu, Feb 4)

•	Q3 2009 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close
	CCBN (Thu, Feb 4)

•	Oculus Innovative Sciences Introduces Microcyn® Solution for Use in Post-Surgical Wounds to U.S. Hospitals and Physicians
	Business Wire (Thu, Jan 28)

•	Oculus Innovative Sciences Fiscal Third Quarter 2010 Call scheduled for Thu, Feb 4
	Shareholder.com (Thu, Jan 28)

•	Oculus Innovative Sciences Announces Fiscal Third Quarter 2010 Financial Results and Corporate Update Release and Conference Call
	Business Wire (Tue, Jan 26)

•	Oculus Innovative Sciences to Present at OneMed Forum 2010 During JP Morgan Week in San Francisco
	Business Wire (Thu, Jan 7)

•	Prospecting for Stocks: Oculus Innovative Sciences
	at Motley Fool (Fri, Dec 4)

•	Oculus Innovative Sciences Provides 2010 U.S. Milestones Update
	Business Wire (Thu, Dec 3)

More Headlines for OCLS...

ANALYST

EPS Est (next year) (Mar-08) :	N/A
EPS Est (in 2 years) (Mar-09) :	N/A
Avg Rec (current)*:	1.5
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Oculus Innovative Sciences, Inc., together with its subsidiaries, operates as a biopharmaceutical company that develops, manufactures, and markets products based on the Microcyn Technology platform, which is intended to help prevent and treat infe...

Full Company Profile

Add to Portfolio

Email to a Friend

•